China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms ...

There is not a single member of AAM who has not raised concerns about the tariff situation,” said the CEO of the generic drug ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Despite increasing competition in the pharmaceutical industry, several generic drug companies are poised for growth. Though generic drugs represent more than 90% of dispensed prescriptions ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

The Medicare $2 Drug List Model included generic drugs for high blood pressure, diabetes and other ailments many elderly face ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Specialty Generics Market 2025-2033" report has been added to ResearchAndMarkets.com's offering. The global specialty generics market size reached ...

US President Donald Trump's executive order imposing a 10 percent tariff on Chinese imports is likely to drive up the cost of generic drugs in the US and exacerbate drug shortages, US media outlet ...